Tizanidine Tablet
Product Images NDC 72162-1641

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 72162-1641). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tizanidine-1 (Tizanidine 1)

Tizanidine-1 (Tizanidine 1)
Chemical structure of Tizanidine, depicting the molecular arrangement including chlorinated aromatic ring, thiazole, and imidazoline components, associated with its hydrochloride form.*
FDA Label Image

Tizanidine-2 (Tizanidine 2)

Tizanidine-2 (Tizanidine 2)
A pharmacokinetic graph showing plasma concentration (ng/ml) of 4 mg Tizanidine tablets and capsules over time (hours) post-dosing. The chart compares concentration profiles with and without food intake, indicating peak plasma levels within the first few hours and decline thereafter.*
FDA Label Image

Tizanidine-3 (Tizanidine 3)

Tizanidine-3 (Tizanidine 3)
A line graph showing the improvement in Ashworth Score over 6 hours post-dose for three groups: 16 mg tizanidine, 8 mg tizanidine, and placebo. The graph includes error bars and shows higher improvement scores for the 16 mg and 8 mg tizanidine groups compared to placebo.*
FDA Label Image

Tizanidine-4 (Tizanidine 4)

Tizanidine-4 (Tizanidine 4)
A line chart depicting improvement in Ashworth Score over time, comparing tizanidine (mean dose 28.8 mg) and placebo groups. The x-axis shows time points: end of titration (week 3), end of maintenance (week 7), and study endpoint (last observation carried forward). The y-axis measures improvement, with tizanidine showing greater positive changes than placebo.*
FDA Label Image

Label (Lbl721621641)

Label (Lbl721621641)
Label for Tizanidine Tablets, USP 2 mg by Bryant Ranch Prepack, containing 1000 tablets. The label states each tablet contains 2.288 mg Tizanidine HCl equivalent to 2 mg of Tizanidine base. It includes storage instructions, a caution to keep medication out of reach of children, and notes that tablets are not interchangeable with capsules. Manufactured by ALKALOIDA Chemical Company Zrt. Barcodes and lot information sections are visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.